Select Page

Company to buy

  • Size: all sizes of businesses
  • Revenue: 5 – 50 million EUR
  • Location of the target company: any country of Europe, EU countries preferred
  • Reason for acquisition: The buyer wants to expand by buying an already established manufacturing facility
  • #CFIE PHB049

Overview of this buyer for a pharmaceutical vaccines manufacturer

The management of a large pharma research company based in Scandinavia has recently started to look for a pharma production facility in continental Europe, with plans of a takeover (acquisition). The target company can be an established manufacturing company with an existing business, or just a manufacturing unit without a production program. It should have all the necessary certification though.

Profile (strategy) of this vaccines manufacturer company buyer

The buyer is a research and development company, which focuses on the development of vaccines against diseases. The buyer has a history of only 10 years, however, multiple vaccines are in the process of development in later stages.

The company is covering the full process, from discovering, developing to commercializing effective vaccines based on its own patented platform. The company is currently working on vaccines against

  • Neck cancer
  • Alzheimer’s
  • Breast cancer
  • Autoimmune diseases
  • Head cancer etc.

In several of the cases, the process has already reached clinical stages. As the development process is nearing its final stage, the managers of the company want to have their own production facility in Europe.

Subscribe as an interested seller
Contact us to get details about this buyer for a vaccine production facility in europe

Activities and products of an ideal target pharma unit

The buyer wants to start its manufacturing activities by buying already established manufacturing facility, in order to produce its own vaccines developed by them.

The target company should have its own manufacturing facility and preferably have its own manufacturing program. However, the buyer will also look at targets without other production activities, e.g. if the owner does not want to sell the whole company, but just a manufacturing unit without a production program.

The revenue or financials of the company are not as important as the owner is planning to perform their own production. On the other hand, the target should not be in loss and should preferably be financially stable.

The target should have all necessary certification to run vaccine manufacturing operations. The goal of the buyer is to acquire a fully regulatory compliant pharmaceutical manufacturing unit in running condition.

Highlights of this vaccines manufacturing facility buyer

  • The buyer is a pharmaceutical company based in Scandinavia, with an ambition to move part of the production in continental Europe
  • The target company should have a certified manufacturing site in Europe with necessary regulatory certifications
  • The buyer is open to an acquisition of a full company or just manufacturing unit, the structure is up to discussion

More information on this buyer for a vaccine production facility in Europe

Please get in touch if you are interested in learning more about this buyer for a vaccine production facility in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this Pharma buyer

Privacy(Required)
en_GBEnglish (UK)